Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

2021543 citationslettergreen Open Access

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 9, Issue 10, pp. 1141-1153

Field-Weighted Citation Impact: 73.96